Ha Do Email & Phone Number

Durham, North Carolina

API (active pharmaceutical ingredient) Development

Plano, Texas, United States

Reata was acquired by Biogen on Sept. 26th, 2023 for $7.3B

Plano, Texas, United States

Experience in reversible covalent drug design targeting rare diseases

Evanston, Illinois, United States

Design and synthesis of human neuronal nitric oxide synthase inhibitors with a focus on improving their brain penetration to develop a novel therapeutic for neurodegenerative diseasesDesign and develop permeability and metabolic stability assays to evaluate physiochemical properties of synthesized inhibitors

Minneapolis, Minnesota, United States

Design and synthesis of dual inhibitors for HIV reverse transcriptase and integraseDesign and synthesis of HIV capsid inhibitors

Houston, Texas, United States

With MD Anderson Professor Scott R. GilbertsonDesign and successfully synthesize natural product Dysiherbaine, a potent and selective agonist of kainate receptors. The design of the synthetic route allows the modification of important functionalities in the late stage of the synthesisDesign and synthesize separase inhibitors to develop a novel therapeutic for refractory breast cancer

Doctor Of Philosophy - Ph.D., Organic Chemistry

PhD Advisor: MD Anderson Professor Scott R. Gilbertson Field of research: total synthesis of natural product, medicinal chemistry, drug.

Bachelor'S Degree, Chemistry

Honor Program